Infection and Chemotherapy : Impact Factor & More
eISSN: 2092-6448pISSN: 2093-2340
Open AccessShare this on:
Key Metrics
CiteScore 
3.9
H-Index
34
SJR
Q2Infectious Diseases
SNIP
1.23
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Infection and Chemotherapy
Infection and Chemotherapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | KOREAN SOC ANTIMICROBIAL THERAPY |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | USD 200 |
| Publication Time | 22 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Korean Society of Infectious Diseases; Korean Society for Chemotherapy |
| Frequency | Quarterly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Infection and Chemotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Infection and Chemotherapy
Reply: NDM-producing Multidrug-resistant Pseudomonas aeruginosa in Korea: A Growing Threat Requiring National Attention
- 1 Mar 2026
- Infection & Chemotherapy
Genetic Insights into Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae from Southern Thailand
- 1 Mar 2026
- Infection & Chemotherapy
Safety and Effectiveness of Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide) in Patients with HIV-1 Infection: Interim Report of a Post-Marketing Surveillance Study in Korea.
- 1 Mar 2026
- Infection & chemotherapy
Characteristics of Drug Resistance Mutations in a Korean HIV/AIDS Cohort, and Risk Factors for Resistance Acquisition in ART-Experienced Patients
- 1 Mar 2026
- Infection & Chemotherapy
Antibiotic Antagonism in Orientia tsutsugamushi Infection: A Narrative Review
- 1 Mar 2026
- Infection & Chemotherapy
Bone Health in People Living with HIV: From Pathophysiology to Practical Management.
- 1 Mar 2026
- Infection & chemotherapy
Reply: NDM-producing Multidrug-resistant Pseudomonas aeruginosa in Korea: A Growing Threat Requiring National Attention
- 1 Mar 2026
- Infection & Chemotherapy
Genetic Insights into Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae from Southern Thailand
- 1 Mar 2026
- Infection & Chemotherapy
Safety and Effectiveness of Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide) in Patients with HIV-1 Infection: Interim Report of a Post-Marketing Surveillance Study in Korea.
- 1 Mar 2026
- Infection & chemotherapy
Characteristics of Drug Resistance Mutations in a Korean HIV/AIDS Cohort, and Risk Factors for Resistance Acquisition in ART-Experienced Patients
- 1 Mar 2026
- Infection & Chemotherapy
Antibiotic Antagonism in Orientia tsutsugamushi Infection: A Narrative Review
- 1 Mar 2026
- Infection & Chemotherapy
Bone Health in People Living with HIV: From Pathophysiology to Practical Management.
- 1 Mar 2026
- Infection & chemotherapy
FAQs on Infection and Chemotherapy
How long has Infection and Chemotherapy been actively publishing? 
What is the publishing frequency of Infection and Chemotherapy?
How many articles did Infection and Chemotherapy publish last year?
What is the eISSN & pISSN for Infection and Chemotherapy?
What is Citescore for Infection and Chemotherapy?
What is the H Index for Infection and Chemotherapy ?
What is SNIP score for Infection and Chemotherapy?
What is the SJR for Infection and Chemotherapy?
Who is the publisher of Infection and Chemotherapy?
